Über die Wirkung von N-(4-Methyl-benzolsulfonyl)-N′-butyl-harnstoff auf die Glukose-6-Phosphatase der Leber

The Science of Nature -     

The ecological basis of boll weevil (Anthonomus grandis Boheman) management

The boll weevil (Anthonomus grandis Boheman), generally considered to be native to Mexico or Central America, spread into the southern United States of America in the late 1800s and seriously threatened the cotton industry. As there were no effective alternatives, pest control specialists studied the insect's ecology and advocated cultural practices that would disrupt its environment and maximize the benefits of natural biological and environmental controls. An ecologically orientated pest management scheme founded on cultural practices emerged well before suitable chemical control technology became available and allowed farmers to live with the weevil problem.Despite the ingenuity of the early management scheme, it frequently did not provide satisfactory boll weevil control gauged by present standards. Control of the pest thus shifted largely from an ecological to a chemical approach as effective synthetic organic insecticides became available after World War II. The chemical approach was successful for a number of years, but problems of insecticide-resistant strains of pests, secondary pest outbreaks, environmental quality, and increased costs of the insecticides have forced pest control specialists to re-emphasize the nonchemical techniques used widely against the boll weevil before World War II and to revive the ecological approach to weevil management.This article examines boll weevil ecology as related to management of the insect and reviews the status and prospects of ecologically-based weevil management techniques in the United States.     

Online-Patentrecherchen — schnelle Antworten auf kritische Fragen

Online searching in publically available patent files opens up interesting possibilities to provide a rapid response to critical questions. A computerized analysis of all patents of leading German pharmaceutical companies over the last decade in important indication areas is described. Supported by subsequent manual processing of individual patents it is shown that duplicate experiments on animals practically never occur.